 |
necitumumab |
|---|---|
| Trade Name | |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-20 00:00:00 |
| Sponsor | Eli Lilly and Company;33 ImClone Drive;Branchburg, New Jersey, 08876 |
Related Access Program
| |
necitumumab |
|---|---|
| Trade Name | |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-20 00:00:00 |
| Sponsor | Eli Lilly and Company;33 ImClone Drive;Branchburg, New Jersey, 08876 |